Valerco SA
7.2 FTEThe score of Valerco shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +2 % Equity +2 % Total assets +183 % Headcount (avg FTE) +29 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Valerco's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €48.5m | ||||
| Net result | −76,280 € | ||||
| Equity | 694,285 € | ||||
| Cash | 329,313 € | ||||
| EBITDA | −72,053 € | ||||
| Total assets | €12.9m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 14 Oct 2026
- Year ended 31 Dec 2024filed on 21 Oct 2025
- Year ended 31 Dec 2023filed on 21 Aug 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 10 Aug 2022
Valerco's financial analysis
- Solvency5.4%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Valerco
Valerco's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0478.658.475
- VAT number
- BE0478658475
- Peppol
- Registered · 0208:0478658475 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 25 Oct 2002
- Registered office
- 2550 Kontich
- Size
- Micro · 7.2 FTE
- Latest accounts
- 2025 · filed on 14 Oct 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Valerco (SA) has been based in Kontich since 2002, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports revenue of €48.5m, a net loss of 76,280 € and equity of 694,285 €. With 7.2 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 5.4%, below the median of its sector (46.0%).
Companies similar to Valerco
Companies in the same business, of comparable size and area, outside its group.
- ixX pharma Wholesale of pharmaceutical and medical goods Antwerp · balance sheet €11.3m
- DE Ceunynck Medical Wholesale of pharmaceutical and medical goods Aartselaar · balance sheet €16.9m
- Cipla Europe Wholesale of pharmaceutical and medical goods Antwerp · balance sheet €40.8m
- Kenvue Belgium Wholesale of pharmaceutical and medical goods Antwerp · balance sheet €32.0m
- Nipro Medical Europe Wholesale of pharmaceutical and medical goods Mechelen · balance sheet €324.7m
- SPGL Ltd Wholesale of pharmaceutical and medical goods · balance sheet €1.01m
- M.Ex.T. BELGIUM Wholesale of pharmaceutical and medical goods Roeselare · balance sheet €13.6m
- Elekta Wholesale of pharmaceutical and medical goods Zaventem · balance sheet €13.1m
Frequently asked questions about Valerco
What is the revenue of Valerco?
According to the 2025 annual accounts filed with the NBB, the revenue of Valerco amounts to 48,514,171 €.
What is the VAT number of Valerco?
In Belgium, the VAT number is the company number prefixed with BE: BE0478658475 for Valerco, if the company is VAT-registered. Its company number (CBE) is 0478.658.475.
Where is the registered office of Valerco?
According to the CBE register, the registered office of Valerco is in 2550 Kontich.
What is the equity of Valerco?
At the close of the 2025 financial year, the equity of Valerco amounts to 694,285 €, a solvency of 5.4% of total assets.
How many people work at Valerco?
7.2 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Valerco?
The register lists 5 active mandates at Valerco. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Valerco
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →